FE

Healthcare · Pharmaceuticals

Fermenta Biotech Ltd (FERMENTA)

₹446.15

Mkt cap
₹1,364 Cr
P/E ratio
29.40
P/B
3.14
Div yield
0.81%
ROE
17.30%
ROCE
20.60%
EPS (TTM)
₹15.18
Book value
₹142
52W range
249–583
Sector
Healthcare

Price history

Previous close

Incorporated in 1951, Fermenta Biotech Ltd manufactures Active Pharmaceutical Ingredient, Aqua CHL, Biotechnology and Nutraceutical products [1]

NSE FERMENTABSE 506414
Health check
Constructive
ValuationFair
ProfitabilityStrong
GrowthModerate
TechnicalsNeutral
52-week range
−23.43% from high
₹446
₹249+79.28% from low₹583
Current
₹446.15
Prev close
₹462.30
Day
−3.49%
Price performance
1D
−4.28%
1W
−6.67%
1M
−3.46%
3M
−3.83%
6M
+44.51%
1Y
—
YTD
+40.12%

Financials

Revenue, profit & margin
P/E ratio
29.4×
FERMENTA is 12% below the sector median of 33.4×
FERMENTA29.4×
Sector median33.4×
 Sep 2023Dec 2023Mar 2024Jun 2024Sep 2024Dec 2024Mar 2025Jun 2025Sep 2025Dec 2025Mar 2026Jun 2026Sep 2026Trend
Sales56.9198.9797.3478.1395.03156.47139.85136.26130.22137.36121.58121.82132.67
YoY Sales growth-41.95%+80.40%-7.44%-5.24%+66.98%+58.10%+43.67%+74.40%+37.03%-12.21%-13.06%-10.60%+1.88%
Expenses70.8273.8491.9677.3376.25103.20102.90108.02103.58112.40101.58103.76112.56
Operating Profit-13.9125.135.380.8018.7853.2736.9528.2426.6424.9620.0018.0620.11
OPM %-24.44%25.39%5.53%1.02%19.76%34.04%26.42%20.73%20.46%18.17%16.45%14.83%15.16%
Other Income-5.532.525.382.822.882.233.898.775.430.9214.144.373.08
Interest3.695.193.393.433.694.082.993.112.583.032.822.543.73
Depreciation5.936.386.466.126.156.085.865.815.415.375.115.205.21
Profit before tax-29.0616.080.91-5.9311.8245.3431.9928.0924.0817.4826.2114.6914.25
Tax %0.00%37.81%884.62%0.00%5.92%16.43%-4.19%23.07%25.17%31.24%29.03%35.13%33.75%
Net Profit-29.079.99-7.14-5.9311.1237.8933.3221.6018.0312.0218.609.539.44
EPS in Rs-9.703.35-2.36-1.983.8712.5411.687.426.144.316.523.313.32
Raw PDF

Earnings

Results dates & reactions
No upcoming results date on calendar.

Fresh quarters land in the Financials table above, tagged NSE until screener catches up.

Avg earnings-day move +2.55% · closed higher next day 1 of last 2
 Q1FY27Q2FY27
Broadcast11 Aug '265 Nov '26
Earnings day−2.11%+7.20%
+1 day−4.92%+3.37%
+5 days−5.74%+11.28%
+15 days+7.61%—
+30 days−1.20%—
FilingXBRLXBRL

Corporate actions

Last 6 months

No recent corporate actions

Dividends, splits, and bonuses in the last six months show up here.

Shareholding

as of Sep 2026
60.12%Promoter
Promoters60.12%3.96
FIIs1.05%0.92
DIIs0.00%0.04
Public36.43%3.24
Ownership trend

Peers

8 companies
Valuation vs quality
P/E × ROCE · bubble = market cap
NameCMPP/EMkt CapDiv YldNP QtrQtr Profit VarSales QtrQtr Sales VarROCE
Sun Pharma.Inds.₹1,867.5036.424,48,0760.86%1,995−10.53%16,199+11.88%20.53%
Divi's Lab.₹11,080.0086.072,94,1390.27%1,127+63.57%3,676+35.40%21.97%
Torrent Pharma.₹4,691.2082.191,78,4380.81%534−10.03%4,979+50.79%15.19%
Laurus Labs₹2,220.0089.521,19,9490.09%436+126.43%2,206+33.44%17.76%
Zydus Lifesci.₹1,192.0026.241,18,9020.08%928−27.96%7,910+29.17%21.14%
Dr Reddy's Labs₹1,377.9041.111,15,0920.58%913−31.35%8,698−1.48%13.04%
Cipla₹1,394.5036.281,12,6600.93%852−35.05%7,404−2.44%15.49%
Fermenta Biotec.₹463.3529.361,3640.81%9−45.90%133+1.88%20.57%
Median: 160 Co.₹449.5033.402,0180.08%13+33.73%179+21.23%14.94%

Filings